Publications by authors named "S P Ashmore"
A Multicenter Prospective Cohort Study of Antibiotics for OnabotulinumtoxinA.
Urogynecology (Phila)
December 2024
Importance: Urinary tract infection (UTI) is the most common complication of intradetrusor onabotulinumtoxinA (BTX-A) injection. Despite this, there are no evidence-based guidelines on antibiotic prophylaxis.
Objectives: Our primary aim was to determine whether antibiotic prophylaxis decreased symptomatic, culture-proven UTI rates within 6 weeks of intradetrusor BTX-A injection.
Article Synopsis
- - The study aimed to analyze adherence rates among women using non-antibiotic methods (like methenamine hippurate, D-mannose, and vaginal estrogen) to prevent recurrent urinary tract infections (rUTIs) and examine factors influencing adherence.
- - A total of 90 women participated, with only 37% adhering to their prescribed regimens, and vaginal estrogen being the most frequently prescribed treatment.
- - Findings indicated that adherence to these non-antibiotic treatments is relatively low, with no specific demographic or clinical factors identified as predictors of compliance, suggesting the need for healthcare providers to check on adherence levels before changing treatment plans.
Introduction And Hypothesis: Sacrocolpopexy (SCP) is the gold standard surgical management of apical pelvic organ prolapse (POP), and increasingly, minimally invasive SCP is being adopted as a primary treatment for advanced uterovaginal prolapse. Patients undergoing surgery for POP consider postoperative improvement in sexual function to be a highly important outcome, and sexual dysfunction and dyspareunia severe adverse events. Therefore, it is crucial to understand the impact of minimally invasive SCP on postoperative sexual function.
View Article and Find Full Text PDFIntroduction And Hypothesis: Sacrocolpopexy is the gold standard for the surgical management of apical prolapse. Over the years, surgical advancements have transformed the procedure from a laparotomy with a hospital stay of several days to a minimally invasive approach with a much shorter hospital stay. One recent innovation has the potential to transform minimally invasive sacrocolpopexy.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluates short-term outcomes of patients undergoing single port robotic hysterectomy with sacrocolpopexy for pelvic organ prolapse at two medical centers from January 2021 to August 2023.
- A total of 69 patients were analyzed, showing a median surgery time of 209 minutes, low pain scores, and minimal blood loss.
- The results indicated high success rates, with 98.3% of patients reporting no vaginal bulge symptoms and 98.0% showing no significant prolapse at follow-up, confirming the safety and effectiveness of the procedure.